Research and experimental development on natural sciences and engineering
LUZMON MEDICAL AS
Revenue 2024
NOK 1.6m
Operating profit
NOK −5.7m
Equity
NOK 74.9m
Incorporated
2010
Share capital
NOK 2.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.6m | |
| Total operating costs | 7.3m | |
| Operating profit (EBIT) | −5.7m | |
| Net financial items | 5.8m | |
| Profit for the year | 73k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 76.7m | |
| of which current assets | 37.9m | |
| Equity | 74.9m | |
| Total liabilities | 1.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.